EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial

Brian O'Sullivan, Song Ounpraseuth, Laura James, Marc Majure, Jason Lang iD, Zhuopei Hu, Alan Simon, Scott Bickel, Brian Ely, L E Faricy, Maryam Garza iD, Melody Greer iD und 13 weitere

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3086 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Brian O'Sullivan und 24 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. Hauptthemen laut MEDLINE: Vitamin D Deficiency, Pediatric Obesity, Asthma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children with asthma and obesity are more likely to have lower vitamin D levels, but the optimal replacement dose is unknown in this population. The objective of this study is identifying a vitamin D dose in children with obesity‐related asthma that safely achieves serum vitamin D levels of ≥ 40 ng/mL. This prospective multisite randomized controlled trial recruited children/adolescents with asthma and body mass index ≥ 85% for age/sex. Part 1 (dose finding), evaluated 4 oral vitamin D regimens for 16 weeks to identify a replacement dose that achieved serum vitamin D levels ≥ 40 ng/mL. Part 2 compared the replacement dose calculated from part 1 (50,000 IU loading dose with 8,000 IU daily) to standard of care (SOC) for 16 weeks to identify the proportion of children achieving target serum 25(OH)D level. Part 1 included 48 randomized participants. Part 2 included 64 participants. In Part 1, no SOC participants achieved target serum level, but 50–72.7% of participants in cohorts A‐C achieved the target serum level. In part 2, 78.6% of replacement dose participants achieved target serum level compared with none in the SOC arm. No related serious adverse events were reported. This trial confirmed a 50,000 IU loading dose plus 8,000 IU daily oral vitamin D as safe and effective in increasing serum 25(OH)D levels in children/adolescents with overweight/obesity to levels ≥ 40 ng/mL. Given the critical role of vitamin D in many conditions complicating childhood obesity, these data close a critical gap in our understanding of vitamin D dosing in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin D DeficiencyPediatric ObesityAsthmaAdolescentChildHumansVitamin DCholecalciferolProspective StudiesVitaminsDietary Supplements

Substanzen

Vitamin DCholecalciferolVitamins

Autor:innen und Institutionen

  • Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Duke University School of Medicine, Durham, North Carolina, USA.
  • National Institutes of Health Office of the Director, Bethesda, Maryland, USA.
  • Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky, USA.

ORCID-Profile: Jason Lang, Maryam Garza, Melody Greer, Mehtap Haktanir Abul, Jade Tam-Williams, Jessica Snowden

Förderung

  • NIH HHS
  • NICHD NIH HHS

Zitieren

APA

O'Sullivan, B., Ounpraseuth, S., James, L., Majure, M., Lang, J., Hu, Z., Simon, A., Bickel, S., Ely, B., Faricy, L. E., Garza, M., Greer, M., Hsia, D., Jefferson, A., Knight, L., Lee, J., Liptzin, D., Haktanir Abul, M., Perry, T. T., …, & ECHO IDeA States Pediatric Clinical Trial Network (2024). Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3086

Vancouver

O'Sullivan B, Ounpraseuth S, James L, Majure M, Lang J, Hu Z, et al. Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3086

BibTeX
@article{OSullivan2024,
  author = {O'Sullivan, Brian and Ounpraseuth, Song and James, Laura and Majure, Marc and Lang, Jason and Hu, Zhuopei and Simon, Alan and Bickel, Scott and Ely, Brian and Faricy, L E and Garza, Maryam and Greer, Melody and Hsia, Daniel and Jefferson, Akilah and Knight, Lisa and Lee, Jeannette and Liptzin, Deborah and Haktanir Abul, Mehtap and Perry, Tamara T and Prior, Fred and SanGiovanni, Christine and Tam-Williams, Jade and Wu, Brian and Snowden, Jessica and ECHO IDeA States Pediatric Clinical Trial Network, ECHO IDeA States Pediatric Clinical Trial Network},
  title = {Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3086}
}
Kostenlos starten →